Chelating Agents: all 161 studies that test it
Page 2 of 2. Open to participants first (10), then studies with results posted, then the rest; newest registration first within each.
- Treatment of Early Stage Renal Failure With Active Vitamin D or a Phosphate Binder.CompletedNCT01231438Phase 2
- FGF23 Reduction : Efficacy of a New Phosphate Binder in CHronic Kidney DiseaseCompletedNCT01220843Phase 3
- Trientine Hydrochloride for the Prevention of Macular Edema Associated With Pan-retinal Photocoagulation for Severe Non-proliferative and Proliferative Diabetic RetinopathyTerminatedNCT01213888Not applicable
- Trientine and Carboplatin in Advanced MalignanciesCompletedNCT01178112Phase 1
- Hydrolyzed Casein and Whey Protein Supplementation and the Addition of Leucine to Induce Protein Anabolism in Malnourished COPD PatientsCompletedNCT01154400Not applicable
- Sevelamer, FGF-23 and Endothelial Dysfunction in Chronic Kidney Disease (CKD)CompletedNCT01135615Phase 4
- Transdermal Absorption of Dimercaptopropane-1-Sulfonate (DMPS) and Effect on Urinary Mercury ExcretionCompletedNCT01059474Phase 1
- Sevelamer Hydrochloride and Femoral and Carotid Intima Media Thickness Progression in End Stage Renal DiseaseCompletedNCT01049815Not applicable
- Nicotinamide Versus Sevelamer Hydrochloride on Phosphatemia Control on Chronic Hemodialysed PatientsTerminatedNCT01011699Phase 3
- Effect of Sevelamer Carbonate on Oxidative Stress in Patients With Diabetic NephropathyCompletedNCT00967629Phase 1
- Effect of Immunocal® With Exercise Versus Casein With Exercise on Aging Processes in Elderly PersonsCompletedNCT00935610Phase 2
- Effect of Sevelamer on Glucose Tolerance and Insulin Sensitivity in Patients With Chronic Renal Failure (CKD)WithdrawnNCT00837655Not applicable
- A Randomised, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of Sevelamer Carbonate Tablets Dosed Three Times a Day in Hyperphosphataemic Chronic Kidney Disease Patients Not on DialysisTerminatedNCT00833768Phase 3
- Differential Effects of Milk Proteins on Postprandial Lipemia in Response to a Fat-Rich Meal in Type 2 DiabetesCompletedNCT00819975Not applicable
- Differential Effects of Protein Quality on Postprandial Lipemia in Response to a Fat-Rich Meal in Type 2 Diabetes: Comparison of Whey, Casein, Gluten, and Cod ProteinCompletedNCT00817973Not applicable
- Dimercaptosuccinic Acid (DMSA) Treatment of Children With Autism and Heavy Metal ToxicityCompletedNCT00811083Phase 1/2
- Effects of Dietary Proteins on Postprandial Lipaemia and Incretin Responses in Obese SubjectsCompletedNCT00809874Not applicable
- Effects of Phosphate Binding With Sevelamer in Stage 3 Chronic Kidney DiseaseCompletedNCT00806481Phase 2
- Study Comparing Tetrathiomolybdate vs Standard Treatment in Primary Biliary CirrhosisCompletedNCT00805805Phase 3
- Benfotiamine Prevents Vascular Dysfunction in Healthy SmokersCompletedNCT00785460Phase 3
- Sevelamer Hydrochloride in Peritoneal Dialysis PatientsCompletedNCT00745589Not applicable
- Reduce Cardiovascular Calcifications to Reduce QT Interval in DialysisCompletedNCT00710788Not applicable
- Optimal Titration Regimen for SBR759 in Lowering Serum Phosphate Levels in Asian Chronic Kidney Disease Patients on HemodialysisCompletedNCT00704678Phase 2
- Reactive Oxygen Species in the Pathogenesis of Diabetic ComplicationsCompletedNCT00703989Not applicable
- A Multicenter, Active and Placebo-controlled Study of Enteric Coated Sevelamer in Patients With Mild to Moderate HypercholesteremiaCompletedNCT00690937Phase 2
- An Open Label Dose Titration of Sevelamer Carbonate Tabs 3 Times a Day in Hyperphosphatemic CKD Patients Not On DialysisCompletedNCT00681941Phase 3
- Exemestane With or Without ATN-224 in Treating Postmenopausal Women With Recurrent or Advanced Breast CancerTerminatedNCT00674557Phase 2
- Benfotiamine in Diabetic NephropathyCompletedNCT00565318Phase 4
- Radiation Therapy and Ammonium Tetrathiomolybdate in Treating Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung CancerWithdrawnNCT00560495Phase 1
- Regulation of Bone Formation in Renal OsteodystrophyCompletedNCT00560300Phase 2
- Sevelamer, Fetuin-A and Endothelial Dysfunction in CKDCompletedNCT00486772Phase 4
- Nuclear Imaging of Human CSF Flow Using Ga-67 Citrate and In-111 DTPATerminatedNCT00477503Phase 1
- Chronic Treatment With Benfotiamine Restores Endothelial Function in People With Type 2 Diabetes MellitusStatus unknownNCT00446810Phase 4
- Cross-Over Study of Sevelamer Hydrochloride and Sevelamer CarbonateCompletedNCT00440648Phase 2
- Effects of Benfotiamine and AGE on Endothelial Function in People With DiabetesCompletedNCT00437008Phase 4
- Study of ATN-224 in Patients With Prostate CancerStatus unknownNCT00405574Phase 2
- Randomized Trial of ATN-224 and Temozolomide in Advanced MelanomaStatus unknownNCT00383851Phase 2
- Mercury Chelation to Treat AutismWithdrawnNCT00376194Phase 2
- Arterial Stiffness and Calcifications in Haemodialysis Patients on Sevelamer or Calcium AcetateWithdrawnNCT00364000Not applicable
- A Study of ATN-224 and Bortezomib in Patients With Multiple MyelomaTerminatedNCT00352742Phase 1/2
- Treatment of Lead-Exposed Children TrialCompletedNCT00342849Phase 3
- Study to Compare Once A Day Sevelamer Dosing With Three Times Per Day Sevelamer DosingCompletedNCT00324376Phase 2
- Study to Compare Sevelamer Carbonate Powder to Sevelamer Hydrochloride Tablets in Patients With CKD on HemodialysisCompletedNCT00268957Phase 3
- Study to Demonstrate Equivalence of Sevelamer Carbonate Powder and Sevelamer HCl Tablets in Haemodialysis PatientsCompletedNCT00267514Phase 3
- EPIC(Effect of PhosLo on Phosphorus Levels in Chronic Kidney Disease)CompletedNCT00211978Phase 3
- CARE-2 (Calcium Acetate [PhosLo®]/Sevelamer[Renagel®] Evaluation Study 2) for Heart Calcification in Dialysis PatientsCompletedNCT00211939Phase 4
- Study of Safety and Efficacy of Renagel® Compared With Calcium Acetate in Patients With Peritoneal DialysisCompletedNCT00196755Phase 3
- Safety Study of Tetrathiomolybdate in Patients With Idiopathic Pulmonary FibrosisCompletedNCT00189176Phase 1/2
- Irinotecan, 5-Fluorouracil, and Leucovorin in Colorectal CarcinomaCompletedNCT00176774Phase 2
- Tetrathiomolybdate in Hormone Refractory Prostate CancerCompletedNCT00150995Phase 2
- Effects of Vitamin B1 in Type 1 Diabetic PatientsCompletedNCT00117026Phase 1/2
- A Study of Tetrathiomolybdate in the Treatment of Psoriasis VulgarisCompletedNCT00113542Phase 2
- Alanosine in Treating Patients With Progressive or Recurrent Malignant GliomasCompletedNCT00075894Phase 1
- Alanosine in Treating Patients With CancerCompletedNCT00062283Phase 2
- Treatment of Hepatocellular Carcinoma With TetrathiomolybdateCompletedNCT00006332Phase 2
- Randomized Study of Succimer (Dimercaptosuccinic Acid) on Growth of Lead-Poisoned ChildrenCompletedNCT00004838Not applicable
- Study of Tetrathiomolybdate in Patients With Wilson DiseaseCompletedNCT00004339Phase 3
- Phase II Study of the Pathophysiology and Treatment With Enalapril and Polystyrene Sulfonate for Pseudohypoaldosteronism, Type ICompletedNCT00004328Phase 2
- Penicillamine, Low Copper Diet, and Radiation Therapy in Treating Patients With GlioblastomaCompletedNCT00003751Phase 2
- A Study of DTC in Patients With AIDS and AIDS Related ComplexCompletedNCT00002069Not applicable
- An Assessment of the In Vivo Biological Effects of Diethyldithiocarbamate (DTC) in HIV-Infected PatientsCompletedNCT00000650Not applicable